Cannara Biotech (FRA:8CB0) Short Percentage of Float


FRA:8CB0 Cannara Biotech Inc FRA:8CB0
62 GF Score
Price €1.08
GF Value €1.00
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cannara Biotech Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:8CB0 vs ZTS, UTHR: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Short Percentage of Float falls into.


FRA:8CB0
62GF Score
Cannara Biotech Inc FRA:8CB0
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cannara Biotech (FRA:8CB0) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be overvalued. The current stock price of €1.08 is trading 8% above its estimated GF Value™ of €1.00. GuruFocus considers Cannara Biotech to be Modestly Overvalued.

Key valuation signals for FRA:8CB0:

  • Short Percentage of Float:
  • GF Value™: €1.00 vs. price of €1.08 (8% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the FRA:8CB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Other Exchanges LOVFF:USALOVE:Canada
Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
62GF Score

Get the complete analysis for FRA:8CB0

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.08
Price
€1.00
GF Value